Evidence map›Paper›PMID 22345445›Full record

ArticleJournal of virology2012

Herpes B virus utilizes human nectin-1 but not HVEM or PILRα for cell-cell fusion and virus entry.

Qing Fan, Melanie Amen, Mallory Harden, Alberto Severini, Anthony Griffiths, Richard Longnecker

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Understanding Primate Herpesviruses.Journal of emerging diseases and virology · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Qing FanDepartment of Microbiology-Immunology, Feinberg School of Medicine of Northwestern University, Chicago, Illinois, USA.
Melanie Amen
Mallory Harden
Alberto Severini
Anthony Griffiths
Richard Longnecker
Northwestern University · USTexas Biomedical Research Institute · USPublic Health Agency of Canada · CAThe University of Texas Health Science Center at San Antonio · US

Funding

WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GAUDUIN, MARIE-CLAIRE ELISABETH · 1999 to 2011
$79.1M
HERPESVIRUS GENE EXPRESSION IN TRANSFORMED CELLSR01CA021776 · NCI · UNIVERSITY OF CHICAGO · PI LONGNECKER, RICHARD M · 1985 to 2017
$4.2M
EBV gB Function in Viral Fusion, Entry, and EgressR01AI067048 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LONGNECKER, RICHARD M · 2007 to 2011
$1.9M
MOLECULAR MECHANISMS OF MICROBIAL PATHOGENICITYT32AI007271 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHONG, GUANGMING · 1985 to 2013
$1.0M
Development of a Vaccine to Protect Monkeys from Herpes B Virus InfectionR21RR026287 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GRIFFITHS, ANTHONY · 2011 to 2011
$219k
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR012087 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI VANDEBERG, JOHN L · 1996 to 1996
–
HERPESVIRUS GENE EXPRESSION IN TRANSFORMED CELLSR37CA021776 · NCI · UNIVERSITY OF CHICAGO · PI SPEAR, PATRICIA G · 1987 to 1994
–
NCI NIH HHS CA021776NCI NIH HHS R01 CA021776NCRR NIH HHS C06 RR012087NCRR NIH HHS P51 RR013986NCRR NIH HHS R21 RR026287NIAID NIH HHS 5T32AI007271NIAID NIH HHS AI067048NIAID NIH HHS R01 AI067048NIAID NIH HHS T32 AI007271
6 · The paper itself

Abstract

To investigate the requirements of herpesvirus entry and fusion, the four homologous glycoproteins necessary for herpes simplex virus (HSV) fusion were cloned from herpes B virus (BV) (or macacine herpesvirus 1, previously known as cercopithecine herpesvirus 1) and cercopithecine herpesvirus 2 (CeHV-2), both related simian simplexviruses belonging to the alphaherpesvirus subfamily. Western blots and cell-based enzyme-linked immunosorbent assay (ELISA) showed that glycoproteins gB, gD, and gH/gL were expressed in whole-cell lysates and on the cell surface. Cell-cell fusion assays indicated that nectin-1, an HSV-1 gD receptor, mediated fusion of cells expressing glycoproteins from both BV and CeHV-2. However, herpesvirus entry mediator (HVEM), another HSV-1 gD receptor, did not facilitate BV- and CeHV-2-induced cell-cell fusion. Paired immunoglobulin-like type 2 receptor alpha (PILRα), an HSV-1 gB fusion receptor, did not mediate fusion of cells expressing glycoproteins from either simian virus. Productive infection with BV was possible only with nectin-1-expressing cells, indicating that nectin-1 mediated entry while HVEM and PILRα did not function as entry receptors. These results indicate that these alphaherpesviruses have differing preferences for entry receptors. The usage of the HSV-1 gD receptor nectin-1 may explain interspecies transfer of the viruses, and altered receptor usage may result in altered virulence, tropism, or pathogenesis in the new host. A heterotypic cell fusion assay resulting in productive fusion may provide insight into interactions that occur to trigger fusion. These findings may be of therapeutic significance for control of deadly BV infections.

Indexed as

Virus InternalizationAnimalsCell Adhesion MoleculesCell FusionCell LineChlorocebus aethiopsCricetinaeGene ExpressionHerpesvirus 1, CercopithecineHumansMembrane GlycoproteinsNectinsReceptors, ImmunologicReceptors, Tumor Necrosis Factor, Member 14Receptors, VirusViral Envelope ProteinsCell Adhesion MoleculesMembrane GlycoproteinsNECTIN1 protein, humanNectinsPILRA protein, humanReceptors, ImmunologicReceptors, Tumor Necrosis Factor, Member 14Receptors, VirusViral Envelope Proteins

Identifiers

PMID22345445
PMCPMC3318624
OpenAlexW1969662184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.